JPRN-jRCT2080223755已完成3 期
An Open-label Study to Assess the Safety, Tolerability, Pharmacokinetics, and Efficacy of S-033188 2% Granules after Administration of a Single Dose to Otherwise Healthy Pediatric Patients with Influenza
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 33
研究概览
简要总结
Single oral dose of S-033188 2% granules investigated in this study is considered to be well tolerated and effective in pediatric patients with influenza virus infection.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 <= 11age old（—）
- 性别
- All
入选标准
- •Patients confirmed with influenza virus infection and within 48 hours from onset.
- •- Patients whose body weight is less than 20 kg.
排除标准
- •- Patients with severe symptoms of influenza virus infection requiring inpatient treatment.
- •- Patients with high risk factors.
- •- Patients with concurrent infections requiring antimicrobial therapy.
研究者
相似试验
已完成
3 期
A Open-label Study of Baloxavir Marboxil Granules in Otherwise Healthy Pediatric Patients With InfluenzaJPRN-jRCT2080224512SHIONOGI & CO., LTD.45
已完成
1 期
Study of a Latanoprost Ocular Implant for Treatment of Open Angle Glaucoma or Ocular Hypertension.Open Angle GlaucomaOcular HypertensionNCT05333419PolyActiva Pty Ltd1
终止
1 期
Ascending Dose Study of Genome Editing by the Zinc Finger Nuclease (ZFN) Therapeutic SB-318 in Subjects With MPS IMPS INCT02702115Sangamo Therapeutics3
已完成
3 期
Study of Repeated Administration of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus ErythematosusLupus Erythematosus, SystemicNCT03427151ImmuPharma62
已完成
1 期
A Study of LY3041658 in Healthy ParticipantsHealthyNCT04653168Eli Lilly and Company16